Where are we with treatment options after first line in small cell lung cancer?—report of two opposite cases treated with CAPTEM regimen and possible perspectives

Autor Cortellini, Alessio, Dal Mas, Antonella, Cannita, Katia, Collina, Guido, Parisi, Alessandro, Pavese, Francesco, Porzio, Giampiero, Verna, Lucilla, Ficorella, Corrado
Vydáno v J Thorac Dis (2018)

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction...

Autor Bruera, Gemma, Massacese, Silvia, Pepe, Francesco, Malapelle, Umberto, Dal Mas, Antonella, Ciacco, Eugenio, Calvisi, Giuseppe, Troncone, Giancarlo, Simmaco, Maurizio, Ricevuto, Enrico
Vydáno v Ther Adv Med Oncol (2019)

Platelet Concentration in Platelet-Rich Plasma Affects Tenocyte Behavior In Vitro

Autor Giusti, Ilaria, D'Ascenzo, Sandra, Mancò, Annalisa, Di Stefano, Gabriella, Di Francesco, Marianna, Rughetti, Anna, Dal Mas, Antonella, Properzi, Gianfranco, Calvisi, Vittorio, Dolo, Vincenza
Vydáno 2014

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation

Autor Napoleoni, Luca, Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Dal Mas, Antonella, Calvisi, Giuseppe, Venditti, Olga, Lanfiuti Baldi, Paola, Cocciolone, Valentina, Ricci, Alessandro, Ficorella, Corrado
Vydáno v Bioengineering (Basel) (2019)

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of...

Autor Bruera, Gemma, Cannita, Katia, Di Giacomo, Daniela, Lamy, Aude, Troncone, Giancarlo, Dal Mas, Antonella, Coletti, Gino, Frébourg, Thierry, Sabourin, Jean Christophe, Tosi, Mario, Ficorella, Corrado, Ricevuto, Enrico
Vydáno 2012

Intensive multidisciplinary treatment strategies and patient resilience to challenge long-term survival in metastatic colorectal cancer: a case report in real life and clinical pra...

Autor Bruera, Gemma, Pepe, Francesco, Malapelle, Umberto, Di Staso, Mario, Dal Mas, Antonella, Di Giacomo, Daniela, Scerbo, Gaia, Santilli, Michela, Ciacco, Eugenio, Simmaco, Maurizio, Troncone, Giancarlo, Coco, Claudio, Giuliante, Felice, Ricevuto, Enrico
Vydáno v Ann Transl Med (2021)

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

Autor Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Lanfiuti Baldi, Paola, Venditti, Olga, D’Orazio, Carla, Dal Mas, Antonella, Calvisi, Giuseppe, Giordano, Aldo V, Vicentini, Vincenzo, Vicentini, Roberto, Felicioni, Lara, Marchetti, Antonio, Buttitta, Fiamma, Russo, Antonio, Ficorella, Corrado
Vydáno v Onco Targets Ther (2019)

Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations

Autor Cocciolone, Valentina, Cannita, Katia, Tessitore, Alessandra, Mastroiaco, Valentina, Rinaldi, Lucia, Paradisi, Stefania, Irelli, Azzurra, Baldi, Paola Lanfiuti, Sidoni, Tina, Ricevuto, Enrico, Dal Mas, Antonella, Calvisi, Giuseppe, Coletti, Gino, Ciccozzi, Antonietta, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Ficorella, Corrado
Vydáno v Oncotarget (2018)

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

Autor Terrenato, Irene, Arena, Vincenzo, Pizzamiglio, Sara, Pennacchia, Ilaria, Perracchio, Letizia, Buglioni, Simonetta, Ercolani, Cristiana, Sperati, Francesca, Costarelli, Leopoldo, Bonanno, Elena, Baldini, Daniela, Candia, Silvia, Crescenzi, Anna, Dal Mas, Antonella, Di Cristofano, Claudio, Gomes, Vito, Grillo, Lucia Rosalba, Pasquini, Paola, Pericoli, Maria Nicoletta, Ramieri, Maria Teresa, Di Stefano, Domenica, Ruco, Luigi, Scarpino, Stefania, Vitolo, Domenico, d’Amati, Giulia, Paradiso, Angelo, Verderio, Paolo, Mottolese, Marcella
Vydáno 2013